Tags

Type your tag names separated by a space and hit enter

Vaccinations for international travellers travelling from Greece.
Travel Med Infect Dis. 2013 Jul-Aug; 11(4):225-30.TM

Abstract

The aim of this prospective, questionnaire-based study is to assess pre-travel vaccinations for international travellers who receive pre-travel advice in Greece. A total of 2494 travellers were studied from January 1, 2009 through December 31, 2010. Travellers sought pre-travel advice at a median of 16 days (range: 0-349 days) before departure. Sub-Saharan Africa was the most common destination (34.7%). Most travellers (60.8%) travelled for <1 month, for recreation purposes (58.9%), stayed in hotels (65.3%), and in urban areas (53.6%). Yellow fever, tetravalent meningococcal, typhoid fever, cholera, and rabies vaccines were administered to 1629 (65.3%), 666 (26.7%), 615 (24.7%), 28 (1.1%), and/or 12 (0.5%) travellers, respectively. Of those who received Yellow fever vaccine, 737 (45.2%) travelled to sub-Saharan Africa, 332 (20.4%) travelled to South America, 949 (58.3%) stayed for short term, and 762 (46.8%) stayed in urban areas. Of the 1629 travellers vaccinated against Yellow fever, 150 (9.2%) and 226 (13.8%) travelled to areas of sub-Saharan Africa and South America respectively, where the vaccine is not or generally not recommended. Of those travellers who received meningococcal vaccine, 327 (49.1%) travelled to the Middle East for the Hajj, 251 (29%) travelled to sub-Saharan Africa, 410 (61.6%) for short term, and 540 (64.4%) stayed in urban areas. Of those travellers who received typhoid vaccine, 241 (39.2%) travelled to sub-Saharan Africa, 78 (12.7%) to the Indian subcontinent, 234 (38%) for short term, and 419 (68.1%) stayed in urban areas. Regarding routine vaccines, tetanus-diphtheria, poliomyelitis, and measles-mumps-rubella vaccines were administered to 707 (28.3%), 639 (25.6%) and/or 149 (6%) travellers, respectively. Of those to whom poliomyelitis vaccine was recommended, 295 (46.2%) and 137 (21.4%) travelled to sub-Saharan Africa and the Middle East, respectively, and 362 (56.7%) travelled for short term. In conclusion, this study revealed that there is a need for more selective vaccine recommendations for travellers to developing countries, taking under consideration travellers and travel characteristics as well. Strategies to target travel health consultants should be developed in order to increase awareness in travel health issues.

Authors+Show Affiliations

Travel Medicine Office, Hellenic Center for Disease Control and Prevention, Athens, Greece.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

23433917

Citation

Pavli, Androula, et al. "Vaccinations for International Travellers Travelling From Greece." Travel Medicine and Infectious Disease, vol. 11, no. 4, 2013, pp. 225-30.
Pavli A, Spilioti A, Lymperi I, et al. Vaccinations for international travellers travelling from Greece. Travel Med Infect Dis. 2013;11(4):225-30.
Pavli, A., Spilioti, A., Lymperi, I., Katerelos, P., & Maltezou, H. C. (2013). Vaccinations for international travellers travelling from Greece. Travel Medicine and Infectious Disease, 11(4), 225-30. https://doi.org/10.1016/j.tmaid.2012.11.007
Pavli A, et al. Vaccinations for International Travellers Travelling From Greece. Travel Med Infect Dis. 2013 Jul-Aug;11(4):225-30. PubMed PMID: 23433917.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vaccinations for international travellers travelling from Greece. AU - Pavli,Androula, AU - Spilioti,Athina, AU - Lymperi,Ioanna, AU - Katerelos,Panagiotis, AU - Maltezou,Helena C, Y1 - 2013/02/20/ PY - 2012/07/16/received PY - 2012/11/20/revised PY - 2012/11/26/accepted PY - 2013/2/26/entrez PY - 2013/2/26/pubmed PY - 2015/4/22/medline KW - Pre-travel KW - Rabies KW - Typhoid KW - Vaccination KW - Yellow fever SP - 225 EP - 30 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 11 IS - 4 N2 - The aim of this prospective, questionnaire-based study is to assess pre-travel vaccinations for international travellers who receive pre-travel advice in Greece. A total of 2494 travellers were studied from January 1, 2009 through December 31, 2010. Travellers sought pre-travel advice at a median of 16 days (range: 0-349 days) before departure. Sub-Saharan Africa was the most common destination (34.7%). Most travellers (60.8%) travelled for <1 month, for recreation purposes (58.9%), stayed in hotels (65.3%), and in urban areas (53.6%). Yellow fever, tetravalent meningococcal, typhoid fever, cholera, and rabies vaccines were administered to 1629 (65.3%), 666 (26.7%), 615 (24.7%), 28 (1.1%), and/or 12 (0.5%) travellers, respectively. Of those who received Yellow fever vaccine, 737 (45.2%) travelled to sub-Saharan Africa, 332 (20.4%) travelled to South America, 949 (58.3%) stayed for short term, and 762 (46.8%) stayed in urban areas. Of the 1629 travellers vaccinated against Yellow fever, 150 (9.2%) and 226 (13.8%) travelled to areas of sub-Saharan Africa and South America respectively, where the vaccine is not or generally not recommended. Of those travellers who received meningococcal vaccine, 327 (49.1%) travelled to the Middle East for the Hajj, 251 (29%) travelled to sub-Saharan Africa, 410 (61.6%) for short term, and 540 (64.4%) stayed in urban areas. Of those travellers who received typhoid vaccine, 241 (39.2%) travelled to sub-Saharan Africa, 78 (12.7%) to the Indian subcontinent, 234 (38%) for short term, and 419 (68.1%) stayed in urban areas. Regarding routine vaccines, tetanus-diphtheria, poliomyelitis, and measles-mumps-rubella vaccines were administered to 707 (28.3%), 639 (25.6%) and/or 149 (6%) travellers, respectively. Of those to whom poliomyelitis vaccine was recommended, 295 (46.2%) and 137 (21.4%) travelled to sub-Saharan Africa and the Middle East, respectively, and 362 (56.7%) travelled for short term. In conclusion, this study revealed that there is a need for more selective vaccine recommendations for travellers to developing countries, taking under consideration travellers and travel characteristics as well. Strategies to target travel health consultants should be developed in order to increase awareness in travel health issues. SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/23433917/Vaccinations_for_international_travellers_travelling_from_Greece_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1477-8939(12)00148-2 DB - PRIME DP - Unbound Medicine ER -